NEW YORK (GenomeWeb News) – Caliper Life Sciences expects to divest additional pieces of its business — with total revenues of between $10 million and $25 million — over the next couple of years, President and CEO Kevin Hrusovsky said last week at the JP Morgan Healthcare Conference.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

In Nature this week: a Danish reference genome, and more.